GYRE icon

Gyre Therapeutics
GYRE

Overview Fund Activity

46 hedge funds and large institutions have $47M invested in Gyre Therapeutics in 2020 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 11 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
–
Holders Change %
0%
% of All Funds
1.02%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
11
Increased
18
Reduced
11
Closed
11
Calls
$492K
Puts
$445K
Net Calls
+$47K
Net Calls Change
+$8K

Top Buyers

1
ACP
Acuta Capital Partners
California
$6.05M
2
SCM
Stonepine Capital Management
Oregon
$4.45M
3
Millennium Management
Millennium Management
New York
$4.8M
4
NCM
Nantahala Capital Management
Connecticut
$6.32M
5
JGC
J. Goldman & Co
New York
$1.43M

Top Sellers

1
MP
Mangrove Partners
Connecticut
$0
2
Marshall Wace
Marshall Wace
United Kingdom
$0
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
$0
4
WG
Winton Group
United Kingdom
$0
5
FM
Fondren Management
Texas
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
GCP
51
GSA Capital Partners
United Kingdom
– -$232K -4,540 Closed
ARTA
52
A.R.T. Advisors
New York
– -$150K -2,930 Closed
EMG
53
Ellington Management Group
Connecticut
– -$129K -2,520 Closed
JPMorgan Chase & Co
54
JPMorgan Chase & Co
New York
– -$102K -1,992 Closed
MWNA
55
Marshall Wace North America
New York
– -$96K -1,889 Closed
PCM
56
Prelude Capital Management
New York
– -$5K -107 Closed
1 2
3